Remarkable discoveries in basic research, driven by astonishingly powerful new technologies and increasingly sophisticated electronic health records, can merge multiple data streams into a massive, secure computational “knowledge network” that
Remarkable discoveries in basic research, driven by astonishingly powerful new technologies and increasingly sophisticated electronic health records, can merge multiple data streams into a massive, secure computational “knowledge network” that enables researchers, companies, and physicians to develop precise prevention, diagnosis, or treatment strategies tailored to each individual, as well as transformative biological concepts, hypotheses and experiments. This approach, called precision medicine, promises to revolutionize American health care and research.
Yet even as science and technology define new opportunities and meet new challenges, outmoded legal, administrative, funding/reimbursement and regulatory policies pose barriers to building the massive connected databases and analytic tools that will be needed to identify, test, and deliver precision medicine solutions to patients.
Fortunately, President Obama and bipartisan Congressional leaders have signaled their support for initiatives and legislation that can accelerate the development of precision medicine technologies and strategies across both the public and private sectors. Please join us as some of America’s leading researchers, innovators, and public policy experts explore the potential of new data and technology platforms to develop customized care and cures, as well as the challenges to be overcome to bring this powerful vision to fruition.
Atul Butte, Director, Institute for Computational Health Sciences, UCSF
Mark Fishman, President, Novartis Institutes for Biomedical Research
Jo Handelsman, Associate Director for Science, White House Office of Science and Technology Policy
Jonathan Hirsch, Founder & President, Syapse
Jeff Huber, Senior Vice President, Google X
Maynard Olson, Professor of Genome Sciences and of Medicine, Adjunct Professor of Computer Science & Engineering, University of Washington
Harold Paz, Executive Vice President and Chief Medical Officer, Aetna
Jennifer Puck, Professor, Departments of Immunology and Pediatrics, UCSF
Keith Yamamoto, Vice Chancellor for Research, UCSF; Executive Vice Dean, School of Medicine; Professor, Cellular & Molecular Pharmacology, UCSF
Panel discussion will be hosted by:
Michael Krasny, Host, KQED\’s Forum
(Friday) 1:00 pm - 5:00 pm